Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7EJV

The co-crystal structure of DYRK2 with YK-2-69

Summary for 7EJV
Entry DOI10.2210/pdb7ejv/pdb
DescriptorDual specificity tyrosine-phosphorylation-regulated kinase 2, [6-[[4-[2-(dimethylamino)-1,3-benzothiazol-6-yl]-5-fluoranyl-pyrimidin-2-yl]amino]pyridin-3-yl]-(4-ethylpiperazin-1-yl)methanone, ... (4 entities in total)
Functional Keywordsphosphorylase kinase, transferase
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight90842.83
Authors
Li, Z.,Xiao, Y.,Yuan, K.,Kuang, W.,Xiuquan, Y.,Yang, P. (deposition date: 2021-04-02, release date: 2022-04-06, Last modification date: 2023-11-29)
Primary citationYuan, K.,Li, Z.,Kuang, W.,Wang, X.,Ji, M.,Chen, W.,Ding, J.,Li, J.,Min, W.,Sun, C.,Ye, X.,Lu, M.,Wang, L.,Ge, H.,Jiang, Y.,Hao, H.,Xiao, Y.,Yang, P.
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
Nat Commun, 13:2903-2903, 2022
Cited by
PubMed: 35614066
DOI: 10.1038/s41467-022-30581-4
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.5 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon